Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 1
2023 1
2024 4
2025 6
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of Second-Line Treatments After Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma and Related Prognostic Factors: A Multicenter Study by the Turkish Oncology Group (TOG).
Majidova N, Yaslıkaya S, Mıldanoglu MM, Coskun A, Ercan Uzundal D, Sahin TK, Akyildiz A, Akbas S, Camanlı U, Sahin E, Atacan H, Bayrakcı I, Sakalar T, Mordag Cicek C, Gunenc D, İlhan N, Unal OU, Alan O, Hamitoglu B, Ozen Engin E, Sever N, Guren AK, Unsal A, Araz M, Erdogan B, Aykan MB, Selcukbiricik F, Guven DC, Ozdemir N, Sahin AB, Bilici A, Kara IO, Yalcın S, Kostek O. Majidova N, et al. Among authors: yaslikaya s. Turk J Gastroenterol. 2025 Apr 7;36(5):293-301. doi: 10.5152/tjg.2025.24784. Turk J Gastroenterol. 2025. PMID: 40241388 Free PMC article.
Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access program.
Tural D, Özkan O, Eylemer Mocan E, Kapar C, Yaslikaya S, Tatlı AM, Akdağ G, Demir H, Bilgetekin I, Selcukbiricik F, Köse F, Sari M, Erdem GU, Sucuoğlu İşleyen Z, Arslan C, Celik S, Evrensel T, Erman M, Kazaz SN, Ozturk B, Çelik H, Özen M, Erel P, Can Şancı P, Ergün Y, Taban H, Kuzu ÖF, Ulaş Kahya B, Arslan AM, Sakin A, Araz M, Okutur K, Akgül F, Mirili C, Sevinç A, Atalah F, Düzköprü Y, Gülbağcı B, Yaşar S, Kandemir N, Kosku H, Aydın E, Erdem D, Guliyev M, Çulha Y, Şahin B, Gürsoy P, Ürün Y. Tural D, et al. Among authors: yaslikaya s. Future Oncol. 2025 Nov;21(27):3499-3505. doi: 10.1080/14796694.2025.2570637. Epub 2025 Oct 16. Future Oncol. 2025. PMID: 41103123
Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turkish oncology group study.
Majidova N, Arak H, Ozalp FR, Bas O, Koker GO, Ozmarasalı EB, Karateke YS, Sakalar T, Yaslikaya S, Onur ID, Akdag G, Ogul A, Guliyev M, Sahin E, Delipoyraz EE, Alkan A, Aydın O, Ilhan N, Alan O, Akbas S, Cağlar Y, Guren AK, Sever N, Ellez HI, Selcukbiricik F, Muhammed Atcı M, Bilici A, Demirci NS, Basoglu T, Karacin C, Kara IO, Yıldız B, Evrensel T, Karaca M, Dizdar O, Atag E, Ozgun A, Kostek O. Majidova N, et al. Among authors: yaslikaya s. Sci Rep. 2025 Jan 25;15(1):3200. doi: 10.1038/s41598-025-87553-z. Sci Rep. 2025. PMID: 39863702 Free PMC article.
Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study.
Beypınar İ, Demir H, Yaslıkaya Ş, Köşeci T, Demir B, Çolak G, Ağaoğlu AB, Şahbazlar M, Şancı PC, Çabuk D, Işık U, Şahin E, Coşkun A, Caner B, Aykut T, Artaç M, Duygulu ME, Sever N, Öksüz S, Turan N, Aykan MB, Tüzün EK, Uysal M, Uğurlu İ, Sakin A, Acar C, Özaşkın D, Şakalar T, Keskinkılıç M, Yavuzşen T, Köse N, Ertürk İ, Yıldırım N, Balçık OY, Alkan A, Selvi O, Erçin E, Ünal OÜ, Karaçin C. Beypınar İ, et al. Among authors: yaslikaya s. Breast Cancer Res Treat. 2024 Dec;208(3):597-604. doi: 10.1007/s10549-024-07456-x. Epub 2024 Aug 9. Breast Cancer Res Treat. 2024. PMID: 39123071
The Effectiveness of Adjuvant PD-1 Inhibitors in Patients With Surgically Resected Stage III/IV Acral Melanoma.
Arak H, Erkiliç S, Yaslikaya Ş, Eylemer Mocan E, Aktaş G, Özdemir M, Semiz HS, Kiliçkap S, Özalp FR, Sever ÖN, Akdağ G, Ağaoğlu AB, Özçelik M, Sari M, Arcagök M, Anik H, Yayla ŞB, Sever N, Açar FP, Bayrakçi İ, Turhal S, Ayhan M, Kuş T; Turkish Oncology Group Study. Arak H, et al. Among authors: yaslikaya s. J Immunother. 2024 Jun 1;47(5):182-189. doi: 10.1097/CJI.0000000000000508. Epub 2024 Mar 11. J Immunother. 2024. PMID: 38333962 Free PMC article.
Palbociclib in liposarcoma: real-world multicenter data from the Turkish Oncology Group (TOG).
Kus F, Yildirim HC, Bayram D, Bal O, Sahin G, Ugrakli M, Demiray AG, Alan O, Koc Kus I, Sirvan F, Yildirim N, Unal OU, Yaslikaya S, Sahin E, Sakalar T, Atalah F, Karhan O, Enki S, Kilickap S, Akin S. Kus F, et al. Among authors: yaslikaya s. J Chemother. 2025 Sep 10:1-9. doi: 10.1080/1120009X.2025.2557678. Online ahead of print. J Chemother. 2025. PMID: 40931603
Comparison of the Efficacy and Safety of 3 Months of CAPOX Followed by 3 Months of Capecitabine and 6 Months of CAPOX/FOLFOX in the Adjuvant Treatment of Low-Risk Stage III Colon Cancer Treated Surgically.
Bardakci M, Demirtas Esmer D, Hafizoglu E, Yaslikaya S, Genc TB, Ozcelik M, Erdat EC, Hendem E, Buyukbayram ME, Alaca Topcu Z, Kalkan Z, Yildirim N, Celebi A, Ergun Y, Paydas S, Tatli AM, Karakas H, Koseci T, Sendur MAN. Bardakci M, et al. Among authors: yaslikaya s. Oncology. 2023;101(11):723-729. doi: 10.1159/000531722. Epub 2023 Jun 28. Oncology. 2023. PMID: 37379817 Free article.
Comparison of Frontline FOLFIRINOX with Fluorouracil-Based and Gemcitabine-Based Chemotherapies in Metastatic Ampullary Adenocarcinoma: A Multicenter Study by the Turkish Oncology Group (TOG).
Kalem A, Kus T, Gokcek S, Unek IT, Sahin TK, Dizdar O, Sagıroglu MF, Bolek H, Urun Y, Yaslıkaya S, Bayram E, Sever N, Bayoğlu IV, Acar O, Erdogan AP, Saray S, Karabuga B, Arslan Yalcıntas U, Efil SC, Sendur MAN, Aykut T, Araz M, Gunes TK, Ozcelik M, Seyyar M, Aktas G, Yalcın S. Kalem A, et al. Among authors: yaslikaya s. J Clin Med. 2025 Aug 20;14(16):5868. doi: 10.3390/jcm14165868. J Clin Med. 2025. PMID: 40869694 Free PMC article.
12 results